diabetes drugs market

Global Diabetes Drugs Market Size, Share, Impact, Growth, Trends, And Forecasts (2019 2028)

  • Published Date: 2022-12-26
  • Report ID: 138095
  • Pages: 200
  • Format: prudent report format

Report Overview

The global Diabetes market size stood at USD 69.7 billion 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The significant growth in the market can be attributed to factors, such as the rising prevalence of diabetes and an increasing number of programs initiated by various health organizations related to health awareness. North America holds a major market share as of 2019, followed by the Asia-pacific region. The increase in the number of diabetes patients is mainly due to increasing obesity among people caused by unhealthy diets and sedentary lifestyles. Based on drugs, Insulin holds a significant share in the market



Market Growth Drivers

Rising awareness about preventive care and technological advancement are among the factors expected to boost market growth. According to the International Diabetes Federation, the global diabetes population is expected to reach 700 million by 2045 from 463 million in 2019. Technological advancement and frequent new product launches are the factors expected to have a propelling effect on the market during the forecast period.

Rising healthcare funding by government and private institutions in the field of diabetes care is contributing to constant improvement in novel diabetes management solutions.


1. Global Diabetes Drugs Market Overview........................
A. Market Size
2. Market Growth Driver and Restraints.......
A. Rise in Global Prevalence of Diabetes Mellitus
B. Growing R&D Investments
C. Rising Cost of Drugs
D. Long Approval Time
3. Diabetes Market Segmentation.............................................
A. Drug Class
I. Insulin
I. DPP-4 Inhibitors
II. GLP-1 Receptor Agonists
III. SGLT2 Inhibitors
IV. Others
B. Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Middle East and Africa Market Analysis
C. Route of Administration
I. Oral
II. Intravenous
III. Subcutaneous
4. Diabetes Major Drugs Market Share.......
A. Market Analysis, Insights and Forecast By Drug Type
5. Competitive Landscape..................
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..................
A. Novo Nordisk Company overview, Product & Services, Strategies & Financials
B. Sanofi Company overview, Product & Services, Strategies & Financials
C. AstraZeneca Company, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape....
A. Policy changes and Reimbursement scenario
8. Factors Driving Future Growth.........
A. New Trends and Development of Cardiovascular drug market
B. Future Opportunities
9. Potential Market Opportunities
A. Potential prospects in the market
10. Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.